Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns
Summary: Health impacts of Mycobacterium tuberculosis (Mtb) and SARS-CoV-2 co-infections are not fully understood. Both pathogens modulate host responses and induce immunopathology with extensive lung damage. With a quarter of the world’s population harboring latent TB, exploring the relationship be...
Main Authors: | Kim R. Chiok, Neeraj Dhar, Arinjay Banerjee |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-05-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S258900422300706X |
Similar Items
-
A modular phage vector platform for targeted photodynamic therapy of Gram-negative bacterial pathogens
by: Annapaola Petrosino, et al.
Published: (2023-10-01) -
Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19
by: Louise Pierneef, et al.
Published: (2023-01-01) -
Diverse bacteriophages for biocontrol of ESBL- and AmpC-β-lactamase-producing E. coli
by: Amira R. Vitt, et al.
Published: (2024-02-01) -
Intracellular peptides in SARS-CoV-2-infected patients
by: Luiz Felipe Martucci, et al.
Published: (2023-09-01) -
Longitudinal study across SARS-CoV-2 variants identifies transcriptionally active microbes (TAMs) associated with Delta severity
by: Priti Devi, et al.
Published: (2023-10-01)